title: Potent and selective inhibition of A-to-I RNA editing with 2'-O-methyl/locked nucleic acid-containing antisense oligoribonucleotides.
abstract: ADARs (adenosine deaminases acting on RNA) are RNA editing enzymes that bind double helical RNAs and deaminate select adenosines (A). The product inosine (I) is read during translation as guanosine (G), so such changes can alter codon meaning. ADAR-catalyzed A to I changes occur in coding sequences for several proteins of importance to the nervous system. However, these sites constitute only a very small fraction of known A to I sites in the human transcriptome, and the significance of editing at the vast majority sites is unknown at this time. Site-selective inhibitors of RNA editing are needed to advance our understanding of the function of editing at specific sites. Here we show that 2'-O-methyl/locked nucleic acid (LNA) mixmer antisense oligonucleotides are potent and selective inhibitors of RNA editing on two different target RNAs. These reagents are capable of binding with high affinity to RNA editing substrates and remodeling the secondary structure by a strand-invasion mechanism. The potency observed here for 2'-O-methyl/LNA mixmers suggests this backbone structure is superior to the morpholino backbone structure for inhibition of RNA editing. Finally, we demonstrate antisense inhibition of editing of the mRNA for the DNA repair glycosylase NEIL1 in cultured human cells, providing a new approach to exploring the link between RNA editing and the cellular response to oxidative DNA damage.
authors: Department of Chemistry, University of California, Davis, CA 95616, USA.
authors: Rena A
authors: RA
authors: Mizrahi
authors: Nicole T
authors: NT
authors: Schirle
authors: Peter A
authors: PA
authors: Beal
mesh_terms: D001483:Base Sequence; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D009696:Nucleic Acids / Q000737:chemistry*; D017393:RNA Editing / Q000187:drug effects*; D016372:RNA, Antisense / Q000494:pharmacology*; D012333:RNA, Messenger / Q000737:chemistry
chemical_list: D009696:Nucleic Acids; D016372:RNA, Antisense; D012333:RNA, Messenger
references: Nucleic Acids Res. 1991 Jun 25;19(12):3359-68
references: 2062653
references: Nature. 1990 Feb 1;343(6257):484-7
references: 2300191
references: RNA Biol. 2010 Mar-Apr;7(2):205-12
references: 20200492
references: Oligonucleotides. 2003;13(6):435-53
references: 15025911
references: RNA. 2004 Oct;10(10):1563-71
references: 15383678
references: Nucleic Acids Res. 2013 Jan;41(2):1113-23
references: 23172291
references: Neuron. 2002 Apr 25;34(3):349-56
references: 11988167
references: Hum Mol Genet. 2000 Sep 22;9(15):2297-304
references: 11001933
references: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3523-8
references: 11904416
references: Curr Top Microbiol Immunol. 2012;353:61-90
references: 21796513
references: Nucleic Acids Res. 2013 Feb 1;41(3):e43
references: 23161691
references: Methods Mol Biol. 2012;867:117-29
references: 22454058
references: J Mol Recognit. 2000 Jan-Feb;13(1):44-53
references: 10679896
references: Org Biomol Chem. 2010 Nov 7;8(21):4898-904
references: 20820662
references: J Biol Chem. 2002 Nov 1;277(44):42205-13
references: 12200441
references: Nucleic Acids Res. 2012 Oct;40(19):9825-35
references: 22885375
references: PLoS One. 2008 Mar 26;3(3):e1844
references: 18365002
references: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14311-6
references: 11106375
references: Brain. 2009 Jan;132(Pt 1):124-35
references: 18927146
references: Nat Biotechnol. 2004 Aug;22(8):1001-5
references: 15258596
references: Biotechnol Bioeng. 1999 Oct 5;65(1):1-9
references: 10440665
references: PLoS Biol. 2004 Dec;2(12):e391
references: 15534692
references: Neurobiol Dis. 2010 Aug;39(2):169-80
references: 20394819
references: J Am Chem Soc. 2008 Oct 8;130(40):13500-5
references: 18781743
references: Genome Res. 2004 Sep;14(9):1719-25
references: 15342557
references: Gene Ther. 2004 Sep;11(18):1391-8
references: 15229633
references: Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8673-7
references: 8378346
references: Science. 2009 May 29;324(5931):1210-3
references: 19478186
references: Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20715-9
references: 21068368
references: Nature. 2000 Jul 6;406(6791):78-81
references: 10894545
references: Nucleic Acids Res. 2005 Sep 09;33(16):5082-93
references: 16155181
references: Nucleic Acids Res. 2003 Jun 1;31(11):2759-68
references: 12771202
references: Nat Biotechnol. 1999 Aug;17(8):788-92
references: 10429245
references: Angew Chem Int Ed Engl. 2007;46(37):7044-7
references: 17691090
references: Nature. 2007 Jun 21;447(7147):941-50
references: 17581577
references: Nat Rev Drug Discov. 2012 Jan 20;11(2):125-40
references: 22262036
references: J Neurosci. 2008 Nov 26;28(48):12834-44
references: 19036977
references: Neurosci Lett. 2003 Aug 7;346(3):169-72
references: 12853111
references: RNA. 2008 Jun;14(6):1110-8
references: 18430892
references: Nucleic Acids Res. 1997 Nov 15;25(22):4429-43
references: 9358149
references: Brain Res Mol Brain Res. 2004 Apr 29;124(1):70-8
references: 15093687
references: Nucleic Acids Res. 1998 Jul 1;26(13):3136-45
references: 9628910
references: Annu Rev Pharmacol Toxicol. 2010;50:259-93
references: 20055705
references: Nat Biotechnol. 2009 May;27(5):478-84
references: 19412185
references: J Am Chem Soc. 2004 Sep 15;126(36):11213-9
references: 15355102
references: J Am Chem Soc. 2009 Aug 26;131(33):11882-91
references: 19642681
references: Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14687-92
references: 11717408
references: Biochemistry. 2008 Jan 29;47(4):1218-27
references: 18171024
references: Nature. 2009 Oct 8;461(7265):809-13
references: 19812674
references: J Neurosci. 2009 Jun 17;29(24):7633-8
references: 19535574